Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus

American Journal of Health-System Pharmacy

Volumn 57, Issue SUPPL. 2, 2000, Pages

  Moise, P A ^a   Forrest, A ^a   Bhavnani, S M ^a   Birmingham, M C ^a   Schentag, J J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antibiotics; Blood levels; Methodology; Outcomes; Pneumonia; Vancomycin

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; BACTERIUM ISOLATION; CLINICAL FEATURE; CONFERENCE PAPER; DATA BASE; DRUG SENSITIVITY; HOSPITAL INFECTION; HUMAN; LOWER RESPIRATORY TRACT INFECTION; PRIORITY JOURNAL; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 0033792689     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/57.suppl_2.s4     Document Type: Conference Paper

References (17)

1. National Nosocomial Infections Surveillance (NNIS) system report. Data summary from January 1990-May 1990, issued June 1999
2. Increasing prevalence of methicillin-resistant Staphylococcus aureus in the United States
3. Genesis of methicillin-resistant Staphylococcus aureus (MRSA): How treatment of MRSA infections is selected for vancomycin-resistant Enterococcus faecium and the importance of antibiotic management and infection control
4. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
5. Staphylococcus aureus with reduced susceptibility to vancomycin - United States
6. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia
7. Fatal case due to methicillin-resistant Staphylococcus aureus: Small colony variants in an AIDS patient
8. Fourth case of vancomycin-resistant Staphylococcus infection reported in US
9. Mathematical examination of dual individualization principles (I): Relationship between AUC above MIC and area under the inhibitory curve for cefmen-oxime, ciprofloxacin, and tobramycin
10. Pharmacodynamics of intravenous cipro-floxacin in seriously ill patients
11. Antibiotic dosing issues in lower respiratory tract infection: Population-derived area under inhibitory curve is predictive of efficacy
12. Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoxime
13. Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumonia in an in vitro model of infection
14. Mathematical examination of dual individualization principles (III): Development of a scoring system for LRTI staging and quantitation of responses to antibiotics: Results in cefmenoxime treated patients
15. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome: Focus on antibacterial agents
16. Vancomycin dosing in life-threatening staphylococcal infections: Need for measuring and achieving high peak serum levels for inoculum-related resistance ('cryptic vancomycin resistance')